Indivior PLC

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

Specialty pharmaceutical company Indivior launched a $100 million share buyback on Thursday after logging a higher profit in the second quarter, helped by strong demand for its opioid addiction treatment, boosting its shares as much as 22%.

Indivior shares soar on $100 mln buyback, opioid addiction drug sales rise

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018). Repurchases Under Current Program now Expected to be Completed by End of July RICHMOND, Va.

Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame

SLOUGH, UK and RICHMOND, Va. , July 25, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending June 30, 2024.

Indivior Announces Q2 2024 Financial Results

NEW YORK CITY, NY / ACCESSWIRE / July 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Shareholders to Contact the Firm Today!

NEW YORK CITY, NY / ACCESSWIRE / July 23, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Shareholders to Contact the Firm Today!

NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC (“Indivior” or “the Company”) (NASDAQ: INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

Indivior PLC (INDV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK CITY, NY / ACCESSWIRE / July 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm Today!

NEW YORK CITY, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm Today!

NEW YORK CITY, NY / ACCESSWIRE / July 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm Today!

Indivior (INDV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for

NEW YORK CITY, NY / ACCESSWIRE / July 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Stockholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Stockholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 16, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Shareholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Shareholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Shareholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm!

Canadian Solar

CSIQ, FMC and INDV have been added to the Zacks Rank #5 (Strong Sell) List on July 12, 2024.

New Strong Sell Stocks for July 12th

NEW YORK CITY, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm!

Indivior (INDV) slashes financial guidance for 2024, primarily to reflect adverse sales conditions of its top-selling opioid drug. It will discontinue the sales of its schizophrenia drug.

Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View

After a 36% crash in their value on Tuesday, shares in drugmaker Indivior PLC (LSE:INDV) were on firmer footing in afternoon trading Wednesday. And, it seems, that at least one leading investment bank is keeping the faith with the group, which specialises in the treatment of addiction and mental illness.

Indivior share price steadies as drug maker finds a friend in the City

U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.1% on Tuesday.

S&P 500 Edges Higher; Indivior Shares Plummet

MONSEY, N.Y., July 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Indivior PLC (Nasdaq: INDV) (“Indivior”) has violated the federal securities laws after the company announced, among other developments, lower than expected SUBLOCADE net revenue in Q2 based on continued adverse market dynamics impacting near-term SUBLOCADE net revenue growth.

INDV Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Indivior PLC for Potential Securities Law Violations

Tuesday, Indivior Plc INDV announced a downward revision of its profit forecast for the year while deciding to cease sales of its schizophrenia drug Perseris.

What's Going On With Addiction And Mental Illnesses-Focused Indivior Stock On Tuesday?

Indivior PLC (NASDAQ:INDV ) Business Update Conference Call July 9, 2024 8:00 AM ET Company Participants Jason Thompson - VP, IR Mark Crossley - CEO Conference Call Participants Max Herrmann - Stifel Thibault Boutherin - Morgan Stanley Paul Cuddon - Deutsche Numis Chase Knickerbocker - Craig-Hallum Carl Byrnes - Northland Capital Markets Operator Good day, and thank you for standing by. Welcome to the Indivior Business Update Conference Call.

News for Indivior PLC Stock (INDV)